Mitochondria are increasingly associated with inflammation. Here, we focus on the relationship between inflammation and adenine nucleotide translocator type 1 (ANT1), which is localized in the mitochondrial inner membrane. ANT1 plays an important role in oxidative phosphorylation, and mutations in the ANT1 gene are responsible for mitochondrial diseases. Ample studies have demonstrated that ANT1 has a critical role in cardiomyocytes and neurons, but little has been reported on its functions in immune cells. We knocked down ANT1 expression in macrophages and examined inflammatory cytokine expression after lipopolysaccharide stimulation. ANT1 knockdown reduces the expression of IL-6. JNK, upstream of IL-6, is downregulated, but other MAP kinases and the NF-jB signaling remain unchanged. These results suggest that ANT1 modulates IL-6 expression through JNK in macrophages.
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Keywords: ANT1; IL-6; JNK; macrophage Mitochondria supply cytoplasmic ATP and are the main intracellular source of reactive oxygen species (ROS) [1] . Mitochondria are increasingly recognized as modulators of inflammation. It has been reported that NLRP3 (Nod-like receptor family, pyrin domain-containing 3) inflammasome senses mitochondrial dysfunction [2] . Mitochondrial ROS promote the production of inflammatory cytokines and bactericidal activity [3] . Indeed, one of the human severe combined immunodeficiencies is caused by mutations in the gene encoding mitochondrial adenylate kinase 2 [4] .
Adenine nucleotide translocator (ANT) is the most abundant protein on the mitochondrial inner membrane. ANT transfers adenosine diphosphate from the intermembrane space to the mitochondrial matrix and ATP from the matrix to the intermembrane space in exchange [5] . Human ANT has four isoforms (hANT1, hANT2, hANT3, and hANT4) whose expression levels vary depending on tissue type [6, 7] . ANT is closely coupled with oxidative phosphorylation and is a component of the mitochondrial permeability transition pore (MPTP), a nonspecific membrane pore that allows permeation of any molecule smaller than 1.5 kDa [1] .
In the present study, we focused on adenine nucleotide translocator type 1 (ANT1) because its gene is responsible for mitochondrial diseases; several ANT1 mutations cause mitochondrial cardiomyopathy, and others lead to adult-onset autosomal-dominant progressive external ophthalmoplegia (OMIM no.609283). Apart from the mitochondrial diseases, ANT1 plays roles in various biological processes. For example, Lin-Hendel et al. reported that the inhibition of ANT1 disrupts the nonradial migration of interneurons, but not the radial migration of cortical projection neurons [8] . Furthermore, ANT1 overexpression causes apoptosis by recruiting NF-jB to mitochondria [9, 10] .
The function of ANT1 has been examined in the heart and the neuron, both of which strongly express ANT1, but its functions in immune cells remain unclear [7, 8, 11, 12] . In the present study, we examined whether ANT1 regulates inflammatory cytokine expression in the macrophage-like cell line, RAW 264.7, because cytokine expression plays important roles in immune cells.
Materials and methods

Cell culture
The mouse macrophage-like cell line RAW 264.7 was cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS, 100 UÁmL À1 penicillin and 100 lgÁmL À1 streptomycin. Cells were grown in a humidified chamber containing an atmosphere of 95% air/5% CO 2 at 37°C.
Bone marrow-derived macrophage (BMDM) culture
Bone marrow cells were obtained from femur and tibia of 8-week-old male C57BL/6 mouse and cultured in RPMI-1640 medium containing 10% FBS, 100 UÁmL À1 penicillin, 100 lgÁmL À1 streptomycin, and 0.01% macrophage colonystimulating factor (M-CSF). After 6 days, the BMDMs were transferred to 3. 
Statistical analysis
All statistical analyses were carried out in R. Quantitative analysis was performed from at least three independent experimental groups. All data are shown as mean AE SD. All statistical analysis was performed using Welch's t test. Statistical significance is indicated as asterisks. *P < 0.05. All n and P values are indicated in figure legends.
Results
ANT1 is expressed in macrophages
Previous studies have shown that ANT1 is strongly expressed in skeletal muscle, heart, and brain [7] . To investigate the roles of ANT1 in the inflammatory response, we examined whether ANT1 was expressed in macrophages, using anti-ANT1 and anti-Iba1 antibodies. Immunocytochemistry revealed that ANT1 was expressed in the BMDMs (Fig. 1A) . Western blot analysis also detected ANT1 in the BMDMs, although the expression level was lower than that in the heart (Fig. 1B) . uniform and more amenable to gene transfection than BMDMs. We confirmed that ANT1 was also expressed in RAW 264.7 cells (Fig. 1C) . These data show that ANT1 is expressed in macrophages.
ANT1 inhibition by siRNA does not induce cell death
We found that ANT1 was expressed in macrophages ( Fig. 1) . Guo et al. recently reported that ANT1 regulated the NLRP3 inflammasome in macrophages [13] . Therefore, in addition to the inflammasome, we hypothesized that ANT1 also regulates inflammatory cytokine expression. To test this hypothesis, we first reduced ANT1 expression in RAW 264.7 cells using siRNA. We transfected ANT1 siRNA into RAW 264.7 and, 12 h later, measured ANT1 expression level by immunocytochemistry and western blotting.
We confirmed that the expression of ANT1 was suppressed by siRNA ( Fig. 2A,B ; to approximately 50% of the level in scrambled siRNA-treated cells). Since previous work has shown that ANT1 induces apoptosis [9] , we examined whether reducing ANT1 expression using siRNA affects cell viability by LDH assay. Interestingly, ANT1 knockdown did not affect cytotoxicity in RAW 264.7 cells (Fig. 2C) .
ANT1 inhibition by siRNA suppresses the expression of IL-6
To further characterize ANT1 in macrophages, LPS was used as a proinflammatory stimulus. We exposed RAW 264.7 cells to LPS and measured the protein level of proinflammatory cytokines in the cells. First, we examined the time-course of cytokine production after LPS stimulation (Fig. 3A) . Western blot analysis revealed that IL-1b and TNFa were upregulated, reaching a peak at 4 h after LPS stimulation. On the other hand, IL-6 was upregulated 12 h after LPS stimulation. We next measured cytokine expressions at multiple time points from 2 to 12 h after LPS stimulation to check if these cytokines were regulated by ANT1. IL-1b and TNFa protein levels at 2, 4, and 8 h after LPS stimulation were not changed by transfection with ANT1 siRNA (Fig. 3B) , whereas IL-6 protein level was significantly reduced by ANT1 siRNA to 46% at 8 h and 41% at 12 h of the level in scrambled siRNA-treated cells (Fig. 3C) . We next examined whether reducing ANT1 expression using siRNA affects IL-6 mRNA in RAW 264.7 cells. IL-6 mRNA level was also reduced in RAW 264.7 transfected with ANT1 siRNA, to 34% at 12 h of the level in scrambled siRNA-treated cells (Fig. 3D) . These results indicate that ANT1 regulates IL-6 expression at the transcriptional level.
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ANT1 knockdown reduces phosphorylation of JNK
MAP kinase signaling pathways (ERK, p38, JNK) and the NF-jB signaling pathway are well-known accelerators of inflammatory cytokine transcription.
We hypothesized that suppression of IL-6 expression by ANT1 siRNA was due to downregulation of MAP kinases or NF-jB. First, we examined the phosphorylation time-course of ERK, p38 and JNK after LPS Western blot analysis showed that phosphorylation of MAPK was highest at 20 min after LPS stimulation. Total ERK (t-ERK), p38 (t-p38) and JNK (t-JNK) was used as a loading control. (B) Western blot analysis showed that ANT1 knockdown did not change phospho-p38 (p-p38) or p-ERK. Total p38 and total ERK were used as loading controls.
Values represent means AE SD (peak time points; n = 6, the other time points; n = 3). (C) Western blot analysis showed that ANT1 knockdown significantly reduced JNK phosphorylation at the peak time point. Total JNK was used as a loading control. Data were converted and presented as the fold changes related to scrambled siRNA. Values of ANT1 siRNA represent means AE SD (the peak time point; n = 6, the other time points; n = 3); *P < 0.05, Welch's t test.
stimulation (Fig. 4A) . Western blot analysis showed that all MAP kinase phosphorylation reached a peak at 20 min after LPS stimulation. Therefore, we examined whether ANT1 knockdown affected MAP kinase phosphorylation at 20 min after LPS treatment, and before and after the peak time. ERK and p38 phosphorylation at all time points was not changed by ANT1 knockdown (Fig. 4B) . On the other hand, JNK phosphorylation was significantly downregulated at 20 min after LPS treatment, to 54% of the level in scrambled siRNA-treated cells (Fig. 4C) . Next, we examined the degradation time-course of IjB, an inhibitor of the NF-jB pathway. IjB degradation peaked at 20 min after LPS stimulation (Fig. 5A ). In the same manner, we examined whether ANT1 siRNA transfection affected IjB degradation at 10, 20, and 30 min after LPS treatment. IjB degradation was not changed at all time points (Fig. 5B) . These results suggest that ANT1 regulates IL-6 expression through an NF-jB-independent pathway, and that JNK is responsible for ANT1-regulated IL-6 expression in RAW 264.7 cells.
Discussion
Immune cell-specific mitochondrial functions are poorly understood, although several mechanisms have been suggested [14] . For example, mitochondrial reactive oxygen is needed for destruction of intracellular microorganisms [14] . In the present study, we focused on the function of ANT1 in immune cells. ANT1 is a critical protein for mitochondrial function and its gene is responsible for mitochondrial diseases [9, 10, 15] . ANT1 functions have been primarily examined in the heart and brain, where ANT1 is strongly expressed [7, 11, 12] , but they have not been clarified in immune cells. The aim of this study was to elucidate the relationship between ANT1 and inflammation. As summarized in Fig. 6 , our results indicate that ANT1 is expressed in macrophages and regulates IL-6 expression through the JNK pathway.
The level of ANT1 expression in macrophages is unknown. However, it was recently reported that ANT1 regulates the inflammasome in a macrophagelike cell line [13] . In the present study, we first compared the amount of ANT1 in macrophages and cardiac muscle. ANT1 was expressed in macrophages, but the amount of ANT1 protein in macrophages is much more less than in cardiac muscle (Fig. 1B) . Despite being low in macrophages, ANT1 is clearly important because ANT1 knockdown caused downregulation of inflammation (Fig. 3) .
ANT1 overexpression is known to cause apoptosis in human embryonic kidney cells [9] . However, whether ANT1 knockdown influences cell viability is still an open question. Our results showed that ANT1 knockdown did not induce cell death 24 h after siRNA transfection in RAW 264.7 cells (Fig. 2C) . Western blot analysis showed that ANT1 knockdown did not change IjB degradation at all time points. GAPDH was used as a loading control. Data were converted and presented as the fold changes related to scrambled siRNA. Values of ANT1 siRNA represent means AE SD (peak time points; n = 6, the other time points; n = 3).
and found that ANT1 knockdown did not reduce phagocytic activity (data not shown). These results suggest that ANT1 knockdown has little influence on cell viability of macrophages. Previous work has shown that ANT1 regulates the inflammasome [13] . We hypothesized that ANT1 regulated not only the inflammasome but also cytokine expression. We therefore examined whether ANT1 affected inflammatory cytokine expression in RAW 264.7 with LPS, and found that the levels of IL-6 mRNA and protein were downregulated (Fig. 3) but the expression levels of IL-1b and TNFa were not changed. As shown in Figs 4 and 5, we also found that the JNK pathway, which regulates IL-6 transcription, was downregulated by ANT1 knockdown, whereas other MAP kinase pathways and NF-jB pathway were unaffected. These data suggest that ANT1 regulates IL-6 production via the JNK pathway (Fig. 6 ). Our data imply that IL-6 transcription is mainly regulated by the JNK pathway, and not by the NF-jB pathway.
NF-jB is well known as a transcription factor for inflammatory cytokines. On the other hand, several studies have reported that NF-jB suppresses excessive inflammation [16, 17] . In this regard, it should be noted that NF-jB reduces ANT1 transcription and expression [18] . Taken together with the present result that ANT1 knockdown reduced IL-6 expression, these observations suggest that NF-jB inhibits excessive inflammation (i.e., production of IL-6) by downregulating ANT1. Our data also suggest that there is no feedback relationship between ANT1 and NF-jB, since reduced ANT1 does not influence NF-jB function. This proposed cascade of NF-jB and ANT1 warrants further investigation in cells or tissues other than macrophages.
ANT1 knockdown induced TNFa production in H9c2, a cardiac-like cell line [11] . These results and our data are inconsistent, suggesting that ANT1 has different roles in immune cells and in cardiomyocytes. Indeed, several studies have reported that ANT1 functions differ among cell types [8, 12, 19] .
In summary, we showed that suppression of ANT1 reduces IL-6 expression via the JNK pathway in macrophages. A number of studies have suggested that mitochondria regulate innate immune responses. ANT1 in macrophages may therefore serve as a good model for exploring the relationships between mitochondria and immune responses. 
